A biotechnology company produces a valuable chemical using an enzyme-catalysed reaction. The enzyme is inhibited by its own product, which accumulates and reduces the reaction rate. To overcome this, the enzyme is immobilised in alginate beads and used in a continuous-flow bioreactor.
Describe the advantages of using the immobilised enzyme in this system compared to using the free enzyme in a batch reactor.